CVS Pharmacy has stopped selling Zantac, as well as its generic version of the heartburn medication, over concerns that they might contain a substance that could cause cancer.
CVS, the largest pharmacy chain in the country, said over the weekend it was suspending sale of Zantac and other products which contain ranitidine until further notice. The US Food and Drug Administration said earlier this month that it has learned that some ranitidine -- acid-reducing and heartburn medicines, including those known by the brand name Zantac -- contain low levels of an impurity that could cause cancer.
Customers can return productsThe nitrosamine impurity known as N-nitrosodimethylamine, or NDMA, has been classified as a probable human carcinogen based on lab tests, and this isn't the first time that it has been detected in a common medication.Read MoreSince last year, the FDA has been investigating NDMA and other impurities in blood pressure and heart failure medicines known as angiotensin receptor blockers or ARBs.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
CVS suspends sales of Zantac brand and generic heartburn drug during safety reviewCVS Health Corp said on Saturday it will discontinue sales the popular Zantac he...
Consulte Mais informação »
CVS suspends sales of Zantac brand and generic heartburn drug during safety reviewCVS Health Corp said on Saturday it will discontinue sales the popular Zantac he...
Consulte Mais informação »
Separate GSK, AstraZeneca trial results may widen ovarian cancer drug useGlaxoSmithKline and AstraZeneca both reported trial results that will likely mak...
Consulte Mais informação »
Results of GSK and AstraZeneca trials may widen ovarian cancer drug useGlaxoSmithKline and AstraZeneca both reported trial results that will likely mak...
Consulte Mais informação »